A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT03558503 · COMPLETED
Trial details
- NCT number
- NCT03558503
- Sponsor
- UroGen Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-01-03
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.